Inotek Pharms Corp Analysis
Inotek Pharms Corp is undervalued with Real Value of 0.0 and Hype Value of 0.0. The main objective of Inotek Pharms delisted stock analysis is to determine its intrinsic value, which is an estimate of what Inotek Pharms Corp is worth, separate from its market price. There are two main types of Inotek Pharms' stock analysis: fundamental analysis and technical analysis. Fundamental analysis focuses on the financial and economic factors that affect Inotek Pharms' performance, such as revenue growth, earnings, and financial stability. Technical analysis, on the other hand, focuses on the price and volume data of Inotek Pharms' stock to identify patterns and trends that may indicate its future price movements.
The Inotek Pharms stock is traded in the USA on NASDAQ Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. Inotek Pharms is usually not traded on Thanksgiving Day, Christmas Day, New Year 's Day, Dr . Martin Luther King Jr 's Birthday, Washington 's Birthday, Good Friday, Memorial Day, Juneteenth Holiday, Independence Day, Labour Day. Inotek Stock trading window is adjusted to America/New York timezone. Here, you can get updates on important government artifacts, including earning estimates, SEC corporate filings, announcements, and Inotek Pharms' ongoing operational relationships across important fundamental and technical indicators.
Inotek |
Inotek Stock Analysis Notes
About 54.0% of the company shares are owned by institutional investors. The company has price-to-book (P/B) ratio of 1.62. Some equities with similar Price to Book (P/B) outperform the market in the long run. Inotek Pharms Corp recorded a loss per share of 1.39. The entity had not issued any dividends in recent years. Inotek Pharmaceuticals Corporation, a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapies for glaucoma and other diseases of the eye in the United States. The company was founded in 1999 and is headquartered in Lexington, Massachusetts. Inotek Pharmaceuticals operates under Biotechnology classification in USA and traded on NASDAQ General Markets exchange. It employs 24 people. To learn more about Inotek Pharms Corp call the company at 646 440-9100 or check out www.inotekpharma.com.Inotek Pharms Corp Investment Alerts
Many investors view ongoing market volatility as an opportunity to purchase more delisted stocks at a favorable price or short it to generate a bearish trend profit opportunity. If you are one of those investors, make sure you clearly understand the position you are entering. Inotek Pharms' investment alerts are automatically generated signals that are significant enough to either complement your investing judgment regarding Inotek Pharms Corp or challenge it. These alerts can help you understand what you are buying and avoid costly mistakes.
| Inotek Pharms Corp is not yet fully synchronised with the market data | |
| Inotek Pharms Corp has some characteristics of a very speculative penny stock | |
| Inotek Pharms Corp has a very high chance of going through financial distress in the upcoming years | |
| Inotek Pharms Corp has high financial leverage indicating that it may have difficulties to generate enough cash to satisfy its financial obligations | |
| Net Loss for the year was (37.6 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Inotek Pharms Corp currently holds about 103.12 M in cash with (34.26 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 3.79. |
Inotek Market Capitalization
The company currently falls under 'Micro-Cap' category with a current market capitalization of 20.69 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Inotek Pharms's market, we take the total number of its shares issued and multiply it by Inotek Pharms's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our stock analysis tools, you can find out how much better you can do when adding Inotek Pharms to your portfolios without increasing risk or reducing expected return.Did you try this?
Run Correlation Analysis Now
Correlation AnalysisReduce portfolio risk simply by holding instruments which are not perfectly correlated |
| All Next | Launch Module |
Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in income. Note that the Inotek Pharms Corp information on this page should be used as a complementary analysis to other Inotek Pharms' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Piotroski F Score module to get Piotroski F Score based on the binary analysis strategy of nine different fundamentals.
Other Consideration for investing in Inotek Stock
If you are still planning to invest in Inotek Pharms Corp check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Inotek Pharms' history and understand the potential risks before investing.
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance |